Article

jdsupra.comjdsupra.com on 2019-10-17 23:06

Federal Circuit Reverses PTAB On Reasonable Expectation Of Success For TARCEVA Patent

In OSI Pharmaceuticals LLC v. Apotex, Inc., the Federal Circuit reversed the PTAB’s determination that a Tarceva® patent was invalid as obvious ...

Related news